Niaid DCR operational task order covid funding in the amount of $3,706,224 for covid related efforts on this task order
Ended Awarded Last action
- Contract number
- 75N91020F00004
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $291,244,978
Award facts
- Contract value 98% obligated
- $297,601,688.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $66,595,960 | |
| Other Administrative Action | -$208,875 | |
| Exercise an Option | $14,347,078 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $69,467,017 | |
| Other Administrative Action | $4,169,376 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $2,133,449 | |
| Exercise an Option | $65,831,440 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $68,909,533 |
Show all 18
About this award
This federal contract award, valued at $3,706,224, is a delivery order issued under prime contract 75N91019D00024 to Leidos Biomedical Research Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The delivery order is for COVID-19 related operational efforts.
Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. that provides a broad range of research, development, and production services to federal agencies, particularly in support of biomedical research programs at the NIH. This award does not have a set-aside designation. Major subcontractors include Apricot Designs, Inc. for laboratory equipment, MR Solutions Inc. for MRI systems, and Mitchell Group Inc. for operational support services. This award supports NIAID's COVID-19 response efforts and ongoing biomedical research programs across disease areas.
Quick answers
Who was awarded contract 75N91020F00004?
75N91020F00004 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2020.
How much is contract 75N91020F00004 worth?
The government has obligated $291,244,978 on 75N91020F00004. Its current value, with exercised options, is $297,601,688.
Which agency awarded contract 75N91020F00004?
National Cancer Institute (National Institutes of Health) awarded 75N91020F00004, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91020F00004 an order under another contract?
Yes. 75N91020F00004 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00004 competed?
The extent of competition for 75N91020F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award